Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers

International Journal of Dermatology

Volumn 46, Issue 1, 2007, Pages 36-42

  Yonezawa, Masao ^a,b   Tanizaki, Hideaki ^a,b   Inoguchi, Naoko ^a,b   Ishida, Masahide ^a,b   Katoh, Mayumi ^a,b   Tachibana, Takao ^a,b   Miyachi, Yoshiki ^a,b   Kubo, Kentaro ^a,b   Kuroyanagi, Yoshimitsu ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATELOCOLLAGEN; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; DERMATOLOGICAL AGENT; GLUCOCORTICOID; HYALURONIC ACID;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ALLOGENEIC CULTURED DERMAL SUBSTITUTES; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; FEMALE; HUMAN; LEG ULCER; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SAFETY; SKIN ULCER; VASCULITIS; WOUND HEALING;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; JAPAN; LEG ULCER; MALE; MIDDLE AGED; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 33845933050     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03107.x     Document Type: Article

References (31)

1. Phillips TJ. Chronic cutaneous ulcers: Etiology and epidemiology. J Invest Dermatol 1994; 102: 38S-41S.
2. Rheinwald JG, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 1975; 6: 317-330.
3. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975; 6: 331-343.
4. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979; 76: 5665-5668.
5. Gallico GG 3rd, O'Connor NE, Compton CC, et al. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984; 311: 448-451.
6. Cooper ML, Hansbrough JF, Spielvogel RL, et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12: 243-248.
7. Hansbrough JF, Christine D, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992; 13: 519-529.
8. Hansbrough JF, Cooper ML, Cohen R, et al. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 1992; 111: 438-446.
9. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996; 19: 350-354.
10. Hansbrough JF, Mozingo DW, Kealey GP, et al. Clinical trials of a biosynthetic temporary skin replacement, dermagraft-transitional covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997; 18: 43-51.
11. Hansbrough JF, Morgan J, Greenleaf G. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994; 115: 633-644.
12. Yamada N, Shioya N, Kuroyanagi Y. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing. Scand J Plast Reconstr Surg 1995; 29: 211-219.
13. Tanaka M, Nakakita N, Kuroyanagi Y. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test. J Biomater Sci Polym Ed 1999; 10: 433-453.
14. Yamada N, Uchinuma N, Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand J Plast Reconstr Surg 1999; 33: 147-154.
15. Kuroyanagi Y, Yamada N, Yamashita R, et al. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artificial Organs 2001; 25: 180-186.
16. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979; 211: 1274-1278.
17. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211: 1052-1054.
18. Bell E, Ehrlich HP, Sher S, et al. Development and use of a living skin equivalent. Plast Reconstr Surg 1981; 67: 386-392.
19. Bell E, Sher S, Hull B, et al. The reconstitution of living skin. J Invest Dermatol 1983; 81: S2-S10.
20. Naughton G. The advanced tissue sciences story. Sci Am 1999; 280: 84-85.
21. Kuroyanagi Y, Kubo K, Matsui H, et al. Manufacturing and banking system for allogeneic cultured dermal substitute. Jpn J Burn Injuries 2003; 29: 28-38.
22. Oka H, Fujitsu M, Suenobu K, et al. Clinical trials with allogeneic cultured dermal substitute (CDS) for the treatment of burns and skin ulcers. Jpn J Burn Injuries 2002; 28: 333-342.
23. Harima N, Ansai S, Wako M, et al. Clinical trials using allogeneic cultured dermal substitutes for skin ulcers. Jpn J Dermatol 2003; 113: 253-264.
24. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute; evaluation in an animal test. J Artif Organs 2003; 6: 64-70.
25. Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003; 6: 138-144.
26. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: Fundamental evaluation. J Biomater Sci Polym Ed 2003; 14: 625-641.
27. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts; Cryopreservation. Artif Organs 2004; 28 (2): 182-188.
28. Benedetti L, Cortivo R, Berti T, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials 1993; 14: 1154-1160.
29. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proceedings of the Natl Acad Sci U S A, 1978; 75: 871-875.
30. Richard JL, Parer-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995; 18: 64-69.
31. Kubo K, Kuroyanagi YA. study of cytokines released from fibroblasts in culture dermal substitute. J Artif Organs 2005; 29 (10): 845-849.